Aptahem receives Turkish patent for the protection of patent family 2
Aptahem AB (publ) announces today that the Turkish patent office has approved the patent application as the first validated country in Europe. The patent was published with the patent number TR2021/013877 T4.The approval by the Turkish patent office provides protection for the company’s lead candidate Apta-1 within the patent family 2 in Turkey until 2037. The validation phase for the other specific countries where Aptahem has applied for patent protection is ongoing, with expected more approvals to come. CEO Mikael Lindstam comments: ”I am very pleased to receive the final approval